ISPOR 2025 News Center

Explore the news and reporting from ISPOR 2025 in the News Center with curated stories on cutting-edge topics from the conference. 

ISPOR 2025

Collaborating to Improve Healthcare Decision Making for All: Expanding HEOR Horizons

The ISPOR 2025 annual, international conference, the largest global conference for health economics and outcomes research (HEOR), is a must-attend event that convenes global thought leaders to discuss the most important and topical issues in HEOR. 

Most Favored Nation Policy ‘Lazy, Misguided,’ But US Price Reforms Politically ‘Inevitable’ [Pink Sheet]

Trump Executive Order on Drug Pricing Draws Mixed Reactions from Industry and Policymakers [The Evidence Base]

Insights from ISPOR: Elevating Real-World Oncology Research Through Clinician Engagement [Journal of Clinical Pathways]

Inside the Third Plenary: Balancing Speed, Scientific Rigor and Patient-Centered Use of Surrogate Endpoints  [The Evidence Base]

Day 3 ISPOR 2025: Daily Round-Ups  [The Evidence Base]

Inside the Second Plenary: The Innovation Driving the Future of HTA [The Evidence Base]

Day 2 ISPOR 2025: Daily Round-Ups [The Evidence Base]

Inside the First Plenary at ISPOR 2025: Unintended Effects of Drug Price Regulation on Innovation [The Evidence Base]

Day 1 ISPOR 2025: Daily Round-Ups [The Evidence Base]

Drug Price Controls Remain “Misguided” Policy [Navlin Daily]

 IRA Already Shaping Patient Access to Prescription Drugs [Navlin Daily]

How Will Inclusion of Part B Drugs Impact Medicare Drug Price Negotiation? [Navlin Daily]

Lack of Clarity in Medicare Drug Price Negotiation Process Presents Challenges, Opportunities [Navlin Daily]

Bringing Perspectives From Canada to the ISPOR 2025 Global Conference  [Canada's Drug Agency (CDA)]

 Navigating State Prescription Drug Affordability Boards [Navlin Daily]

Prelaunch Collaboration with Payers Improves Patient Access to New Therapies  [Navlin Daily]

Join the ISPOR 2025 Path to Wellness Challenge [Heka Health]

Exploring Sessions on Drug Pricing and the Inflation Reduction Act at ISPOR 2025 [The Evidence Base]

Exploring Sessions on Real-World Data and Real-World Evidence at ISPOR 2025 [The Evidence Base]

Exploring Sessions on Value Assessment at ISPOR 2025 [The Evidence Base]

Exploring Sessions on Patient Centricity at ISPOR 2025 [The Evidence Base]

Exploring Sessions on Health Economics at ISPOR 2025 [The Evidence Base]

Exploring Sessions on Health Technology Assessment at ISPOR 2025 [The Evidence Base]

Countdown to Montreal: Behind the Scenes of ISPOR 2025  [The Evidence Base]

Preview of the ISPOR 2025 Plenary Sessions  [The Evidence Base]

[Video] Patti's People - Patti Peeples Speaks With ISPOR CSO Laura Pizzi   [The Evidence Base]

Your Guide to ISPOR 2025 [The Evidence Base]

ISPOR 2025: First Look at the Conference Program [The Evidence Base]

Photo Gallery

Additional News From the Conference

Check back to view additional news stories from ISPOR 2025 that are added to the News Center as they are published.

Beyond ISPOR 2025: Shaping the Next Chapter of HEOR [TriNetX]

Reflections from ISPOR 2025 in Montreal: Energizing Patient Access, Building Synergies, and Empowering Solo HEOR Professionals [Evelyn Rizzo via LinkedIn]

Canada’s Drug Agency Leaders Will Join Experts From Canada and Abroad at ISPOR 2025 [CDA]

Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment [National Pharmaceutical Council]

CapeStart Helps Life Science Teams Scale Faster, Boost Productivity with New Release of MadeAi™ [READ]

Neurocrine Biosciences (NBIX) Presents Data Adding to the Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients with Tardive Dyskinesia [StreetInsider.com]

[Video] Petauri Evidence at ISPOR 2025 in Montreal [Petauri YouTube Channel]

The Data Revolution: How Loopback Analytics and Cornerstone AI are Transforming Healthcare [Parsers VC]

BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat) [BioSpace]

Amplity Studies At ISPOR 2025 Highlight Trends In GLP-1 Receptor Agonists & Biologic Treatments For UC & CD Patients [IEN Presswire]

Neurocrine Biosciences Presents Findings Contributing to the Growing Body of Evidence on the Impact of High-Dose Glucocorticoids on Clinical Outcomes in Congenital Adrenal Hyperplasia [FirstWord Pharma]

Altis Labs Unveils New AI-Powered External Control Arm Product Offering at ISPOR 2025Dystrophy at ISPOR 2025 [IEN Presswire]

Retrospective Analysis of US Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other Epinephrine Auto-Injectors [Globe Newswire]

ITF Therapeutics LLC to Present Patient-Reported Outcome Data for DUVYZAT® (givinostat) in Duchenne Muscular Dystrophy at ISPOR 2025 [BioSpace]

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS [The Globe and Mail]

CapeStart Helps Life Science Teams Scale Faster, Boost Productivity with New Release of MadeAi™, Award-Winning GenAI Platform [Business Wire]

Komodo Health's Real-World Evidence Platform Drives 31 Patient Journey Research Studies at ISPOR 2025 [Morningstar]

OneMedNet Enhances Data Discovery and Analytics with the Datavant Connect platform and Amazon Web Service (AWS) Clean Rooms [Financial Times]

Integral Announces Panel Presentation at ISPOR 2025 [BioSpace]

OM1 to Present Groundbreaking Research on GLP-1 Agonists and Suicidal Ideation at ISPOR 2025 [Morningstar]

Trinity Life Sciences  Is Presenting and Exhibiting at ISPOR 2025 [Trinity]

What to Look for at ISPOR 2025 – Regulations & Pricing [Jean-Etienne's Blog]

[Video] RTI Health Solutions at ISPOR 2025 in Montreal [RTI Health Solutions]

OPEN Health Announces Mission-Level Corporate Partnership With ISPOR and ISPOR 2025 Activities [Open Health]

See the Real-World Evolution at ISPOR [Evidera]

Ontada Illuminates the Power of its Real-World Evidence to Improve Health Outcomes for People with Cancer at ISPOR 2025 [BioSpace]

Connect with Aetion at ISPOR 2025 [Aetion]

Meet Truveta at ISPOR 2025 [Truveta]

Flatiron Health Announces Research to Be Presented at ISPOR 2025 [Yahoo! Finance]

Meet Avalere Health at ISPOR [Avalere Health]

Genesis Research Group Announces Inaugural Membership of ISPOR Corporate Partnership Program and ISPOR 2025 Attendance [PMLiVE]

Join The Center for Innovation & Value Research at ISPOR 2025 [Center for Innovation & Value Research]

Where to Meet Premier Applied Sciences at ISPOR 2025 [Premier Applied Sciences]

Meet Castor at ISPOR 2025 [Castor]

BlueRidge Life Sciences is at ISPOR 2025 in Montreal! [BlueRidge]

Ascelia Pharma Announces Acceptance of Study on Burden of Illness Real-World Data of Orviglance Target Patients for Presentation at the ISPOR 2025 Conference [TradingView]

Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025 [FirstWord Pharma]

Meet Cytel at ISPOR 2025 Booth #1824 [Cytel]

Alira Health Is Attending ISPOR 2025 [Alira]

Join OM1 at ISPOR 2025 [OM1]

Let’s Meet at ISPOR 2025's Stand 504 [Access Infinity]

Meet Fortrea’s Patient-Centered Endpoints Consulting Team at ISPOR 2025 [Fortrea]

PicnicHealth at ISPOR 2025 [PicnicHealth]

Analysis Group HEOR Consultants to Present at ISPOR 2025 [Analysis Group]

CapeStart to Attend ISPOR 2025 [CapeStart0]

ADVI Health is Attending ISPOR 2025 Annual Conference [ADVI Health]

Meet MarketScan at ISPOR 2025 [Merative]

MMIT Attending ISPOR 2025 [ MMIT]

UBC Attending ISPOR 2025 [UBC]

Komodo Health Will Be in Montreal for ISOR 2025 [Komodo Health]

Join Panalgo at ISPOR 2025 in Montreal! [Panalgo]

Tempus Will Demo Its Latest AI-Enabled Technology at ISPOR 2025 [Tempus]

HEOR News Desk

ISPOR's HEOR News Desk curates the latest HEOR-related news from a variety of news site around the world. 

HEOR News Desk

ISPOR News Webpage

Find the latest ISPOR news and announcements on the Society’s news site.

ISPOR News

Thank You to ISPOR 2025 Media Partners:

A special thank you to the ISPOR 2025 Media Partners—The Evidence Base, Market Access Today, Clinical Leader. Clinical Tech Leader, Journal of Medical Economics—and to all the media outlets who are reporting on the conference.

Disclaimer:

The reporting on ISPOR 2025 from external news sources reflects the views of the authors/media outlets and is not endorsed by ISPOR.